Volume: 39 Issue: 03

1. Clinical dilemmas in non-alcoholic fatty liver disease Page:207—209
2. Clinical characteristics of non-alcoholic fatty liver disease related hepatocellular carcinoma Page:210—213
3. Drug therapy for non-alcoholic fatty liver disease Page:214—217
4. Diagnosis and treatment of patients with lean non-alcoholic fatty liver diseases Page:218—221
5. Exercise prescription for non-alcoholic fatty liver disease Page:222—226
6. Dietary modification in patients with nonalcoholic fatty liver disease Page:227—230
7. Influence of type 2 diabetes treatment on patients with non-alcoholic fatty liver disease Page:231—234
8. Interpretation of Chinese and foreign guidelines for the diagnosis and management of nonalcoholic fatty liver disease Page:235—238
9. Clinical application of linked color imaging in gastrointestinal endoscopy Page:239—244
10. Damage of dual antiplatelet drug to gastrointestinal mucosa and endoscopic diagnosis and treatment Page:245—248
11. Diagnostic accuracy of RPR, FIB-4, APRI and AAR in liver fibrosis patients with chronic hepatitis B Page:249—253
12. Clinical control study of water colonoscopy and gas colonoscopy Page:254—256
13. Study on the expression of antiphospholipid antibody subtypes in primary glomerulopathy Page:257—259
14. The role of probiotic on protein energy wasting and micro-inflammation in peritoneal dialysis patients Page:260—264
15. Changes of biochemical indicators in maintenance hemodialysis patients before death Page:265—269
16. Study on the value of serum galactose-deficient IgA1 in the diagnosis of IgA nephropathy Page:270—273
17. Change of ultrasonographic signs during urate lowering therapy in patients with gout Page:274—277
18. Comparative study on etiology and complications of liver cirrhosis in a 5-year period Page:278—281